Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01508390
NA

Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate

Sponsor: Boston Medical Center

View on ClinicalTrials.gov

Summary

In this study, participants will have standard Androgen Deprivation Therapy and undergo standard external beam radiation therapy to the prostate and at-risk lymph nodes by Intensity Modulated Radiation Therapy. The subsequent \*boost\* radiation therapy to the prostate alone will be given using the CyberKnife, rather than using the standard Intensity Modulated Radiation Therapy. This study will also see how CyberKnife affects the quality of the participant's life.

Official title: Phase II Study of Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate for Treatment of Localized, Non-Metastatic, High Risk Prostate Cancer

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

35

Start Date

2011-06

Completion Date

2027-12

Last Updated

2025-06-26

Healthy Volunteers

No

Conditions

Interventions

RADIATION

CyberKnife Boost

21 Gy in 7 Gy per day, 3 fractions, Every other day

Locations (1)

Boston Medical Center

Boston, Massachusetts, United States